Filing Details

Accession Number:
0000874015-20-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-29 21:47:59
Reporting Period:
2020-06-25
Accepted Time:
2020-06-29 21:47:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1335073 Breaux Castleman C/o Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-25 10,000 $26.66 25,183 No 4 M Direct
Common Stock Disposition 2020-06-25 10,000 $60.00 15,183 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (right to buy) Disposition 2020-06-25 10,000 $0.00 10,000 $26.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2017-06-25 2023-06-24 No 4 M Direct
Footnotes
  1. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on March 5, 2020.